🇺🇸 FDA
Pipeline program

PEG-rhG-CSF

CSPC-JYL-CC-01

Approved small_molecule active

Quick answer

PEG-rhG-CSF for Cervical Cancer is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Cervical Cancer
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials